Ongoing trade disputes, political divisiveness, geopolitical threats, and tense feelings about Russia meddling have no doubt weighed on investor sentiment. Though the S&P 500 is up year-to-date, volatility has been pervasive and global stocks are still in negative territory. Uncertainty hangs over the market like a dark cloud.
But there's sun poking through those dark clouds, and it's none other than U.S. corporate earnings reports! Indeed, earnings have offered a bright spot amidst the negativity, and now in their second week, earnings have been impressing the street and renewing optimism amongst investors for stocks.
Here are a few highlights from this week:
Shares of Eli Lilly were climbing Tuesday on the pharmaceutical company's announcement that it earned $1.55 billion, or $1.50 per share, which was far ahead of analysts estimates of $1.30 per share. Eli Lilly also announced that it would file an IPO for its animal health unit, which the street cheered. Last quarter, Eli Lilly's net income was $1.01 billion, or 95 cents per share. On the revenue front, Eli Lilly hit $6.36 billion, up 9% from the year-ago quarter and above estimates of $6.05 billion. Lilly has approved a plan to buy back $8 billion in stock.
In the telecommunications sector, Verizon shares were also notching higher on reported earnings of $1.20 a share, above a consensus estimate of $1.14. This is good news for the telecom sector, which has taken a beating so far this year, down some 12% year to date while the S&P 500 is in modestly positive territory. AT&T will be one to watch this week as well, to see if telecom can keep getting a much needed boost.
LLY's Aroon Indicator triggered a bullish signal on June 26, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 328 similar instances where the Aroon Indicator showed a similar pattern. In of the 328 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where LLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 359 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for LLY moved out of overbought territory on June 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LLY as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for LLY turned negative on June 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
LLY moved below its 50-day moving average on June 27, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LLY crossed bearishly below the 50-day moving average on July 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
LLY broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (67.114) is very high in comparison to the industry average of (5.632). P/E Ratio (131.129) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.440) is also within normal values, averaging (3.004). Dividend Yield (0.006) settles around the average of (0.161) among similar stocks. LLY's P/S Ratio (20.121) is very high in comparison to the industry average of (3.643).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of pharmaceutical products
Industry PharmaceuticalsMajor